Invesco Dorsey Wright Emerging Markets Momentum ETF (PIE)

NASDAQ: PIE · Real-Time Price · USD
33.00
-0.40 (-1.18%)
Jul 1, 2026, 10:00 AM EDT - Market open
Assets$235.14M
Expense Ratio0.90%
PE Ratio20.88
Shares Out8.00M
Dividend (ttm)$0.57
Dividend Yield1.73%
Ex-Dividend DateJun 22, 2026
Payout FrequencyQuarterly
Payout Ratio35.48%
Volume6,819
Open32.82
Previous Close33.40
Day's Range32.81 - 32.91
52-Week Low20.39
52-Week High35.17
Beta0.83
Holdings115
Inception DateDec 28, 2007

About PIE

Fund Home Page

The Invesco Dorsey Wright Emerging Markets Momentum ETF (PIE) is an exchange-traded fund that mostly invests in total market equity. The fund tracks an index of stocks in emerging markets that show high relative strength characteristics. PIE was launched on Dec 28, 2007 and is issued by Invesco.

Asset Class Equity
Category Diversified Emerging Mkts
Region Global
Stock Exchange NASDAQ
Ticker Symbol PIE
ETF Provider Invesco
Index Tracked Dorsey Wright Emerging Markets Technical Leaders Index (Net)

Top 10 Holdings

29.56% of assets
NameSymbolWeight
Marketech International Corp.61963.83%
Accton Technology Corporation23453.71%
United Integrated Services Co., Ltd.24043.50%
Topco Scientific Co.,Ltd.54343.26%
Sigurd Microelectronics Corporation62573.10%
Taiwan Semiconductor Manufacturing Company Limited23302.91%
Yankey Engineering Co., Ltd.66912.51%
Nanya Technology Corporation24082.50%
Winbond Electronics Corporation23442.13%
TISCO Financial Group PCL Units Non-Voting Depository ReceiptTISCO-R.BK2.13%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Jun 22, 2026$0.21801Jun 26, 2026
Mar 23, 2026$0.02647Mar 27, 2026
Dec 22, 2025$0.24204Dec 26, 2025
Sep 22, 2025$0.08093Sep 26, 2025
Jun 23, 2025$0.20831Jun 27, 2025
Mar 24, 2025$0.00798Mar 28, 2025
Full Dividend History

Performance

PIE had a total return of 62.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.08%.

News

US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals

The U.S. ​Food and Drug Administration launched a pilot program on Monday aimed at allowing the ‌agency to monitor clinical trial data in real time, a step the agency said could cut years from drug ap...

Other symbols: IHEPPHXPH
2 months ago - Reuters